WHIPgroup obtained issuance of U.S. Patent No. 10,143,555 for its client Oxford Performance Materials, Inc. for Customized Implants for Bone Replacement after the examiner initially rejected claims as being anticipated or obvious over other references. The patent covers the clients OSTEOFAB® implants which are produced from polyetherketoneketone (PEKK) using a proprietary 3D printing process. In one commercial use, the OsteoFab® Patient Specific Cranial Device (OPSCD) is intended for the replacement of bony voids in the cranial skeleton. The OPSCD is constructed with the use of the patient’s CT imaging data and computer aided design to determine the dimensions of each implant. The device is then manufactured via the OsteoFab® 3D printing laser sintering process. The OPSCD is attached to native bone with commercially available cranioplasty fixation systems and is a non-load bearing, single use device that is sterilized at the healthcare facility using validated steam sterilization cycles.
WHIPGroup previously filed a Motion to Dismiss a patent infringement suit filed against its client TomTom in the Western District of Texas. Rather than opposing WHIPGroup’s motion to dismiss, Plaintiff MDSP Technologies LLC voluntarily dismissed [Read More…]
WHIPgroup succeeded in having anticipation and indefiniteness rejections overturned by the Patent Trial and Appeal Board (PTAB). The claimed invention relates to a sequencing station that manages both sequencing and restacking tasks. The Examiner had [Read More…]
WHIPGroup filed a Motion to Dismiss for improper venue in the Western District of Texas on behalf of its client TomTom North America, Inc. Plaintiff MDSP Technologies LLC alleges that TomTom North America, Inc. infringes [Read More…]